Market Risers: N4 Pharma, Northbridge Industrial Services, Open Orphan, Pearson

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

The trading price for N4 Pharma company symbol: LON:N4P has climbed 6.54% or 0.43 points throughout the session so far. Traders have stayed positive throughout the trading session. The high for the period has peaked at 6.93 and a low of 6.5. The number of shares traded by this point in time totalled 800,268 while the average shares exchanged is 1,843,325. A 52 week high for the stock is 16 amounting to 9.5 points in difference to the previous days close of business and a 52 week low sitting at 2 which is a variance of 4.5 points. N4 Pharma now has a 20 moving average of 7.23 and now the 50 day SMA of 7.07. The market capitalisation currently stands at £10.81m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for N4 Pharma being recorded at Friday, November 20, 2020 at 11:43:21 AM GMT with the stock price trading at 6.93 GBX.

The trading price for Northbridge Industrial Services with ticker code: LON:NBI has gained 13.77% or 9.78 points during today’s session so far. Buyers have remained positive during this period. Range high for the period has seen 80.78 dropping as low as 74.9. The volume total for shares traded up to this point was 31,843 whilst the average number of shares exchanged is 52,051. A 52 week high for the stock is 165 some 94 points in difference to the previous days close of business and a 52 week low sitting at 62.16 which is a difference of 8.84 points. Northbridge Industrial Services has a 20 day moving average of 69.12 and the 50 day SMA of 73.73. The current market cap is £22.54m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Northbridge Industrial Services being recorded at Friday, November 20, 2020 at 11:41:20 AM GMT with the stock price trading at 80.78 GBX.

The trading price for Open Orphan with company EPIC: LON:ORPH has moved up 4.68% or 1.1 points during today’s session so far. Market buyers have remained optimistic during this period. The periods high has reached 25 dropping as low as 23.5. Volume total for shares traded at this point reached 822,571 while the average shares exchanged is 5,344,269. A 52 week high for the stock is 32.45 amounting to 8.95 points in difference to the previous days close of business and a 52 week low sitting at 4.51 which is a difference of 18.99 points. Open Orphan has a 20 SMA of 26.22 and now a 50 day moving average at 23.38. The market cap now stands at £164.32m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Open Orphan being recorded at Friday, November 20, 2020 at 11:50:26 AM GMT with the stock price trading at 24.6 GBX.

The trading price for Pearson with company EPIC: LON:PSON has increased 2.19% or 14 points throughout today’s trading session so far. Traders have remained positive during the session. Range high for the period has seen 660.4 and a low of 636. The total volume of shares traded by this point was 1,304,211 while the average shares exchanged is 2,985,497. The 52 week high is 677.8 about 38.8 points different to the previous business close and a 52 week low sitting at 412.08 a difference of some 226.92 points. Pearson now has a 20 simple moving average of 567.34 and a 50 day simple moving average now of 554.54. The current market capitalisation is £4,916.92m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Pearson being recorded at Friday, November 20, 2020 at 11:52:44 AM GMT with the stock price trading at 653 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Pearson plc (LON:PSON) reports robust H1 2024 results with steady sales and adjusted operating profit. Guidance for 2024 and 2025 remains unchanged.
Pearson plc (LON:PSON) has released its 2024 Q1 Trading Update, showing strong operational progress and growth momentum for the second half of the year.
Join N4 Pharma Plc for a pre-recorded webinar on their recent Collaboration Agreement with SRI International Inc. Available on 7 May 2024 at 10:00 BST.
N4 Pharma Plc partners with SRI International to combine Nuvec® with FOX Three MGS, aiming to enhance nucleotide therapies for cancer and vaccines.
N4 Pharma Plc (LON:N4P) unveils its audited results for 2023, showcasing advancements in its innovative Nuvec® delivery system for cancer treatments and vaccines.

Search

Search